The Asia-Pacific healthcare/medical simulation market is broadly segmented into products and services. The market was valued at $312 million in 2016 and is poised to grow at a CAGR of 19.89% in the forecast period to reach $688.2 million by 2021.
The major driving force for the market are Increasing healthcare costs, Continuous innovation in technology, and increasing demand for noninvasive technologies. While major constraint for the market are Increasing cost of medical simulators, Economic slowdown, and limited funds issued by the government.
The market is divided based on Type of products(Software, Human Patient Simulators, Interventional simulation, Task traines/ Low fidelity, Anciliary products, Imaging simulation, Simulation education, Simulated Clinical Enviornments), based on geography North America, Europe, Asia-Pacific and ROW. The Americas form the largest regional market for medical simulation, Europe closely follows the America in terms of huge growth and increasing population of aged people. Asian countries such as India, China, South Korea, Malaysia, Thailand, and Singapore are likely to provide a growing market due to their increasing per capita income and emerging economy.
Prominent players in this market are Laerdal Medical (Norway), CAE Healthcare (Canada), Simulaids (U.S.), Gaumard (U.S.), Kyoto Kagako (Japan), Limbs and Things (U.K.), Education Management Solutions (U.S.), and Mentice AB (Sweden).
What makes our report unique?
1) A wide and in depth analysis of the market trends and future forecasts based on the type of products .
2) We provide longest possible market segmentation based on products and geography. We give you the competitive landscape of major players in the market and market share based on the products, and recent developments.
3) We give you the profiles of key players including company profile, Financial overview, Business strategy and developments in the market to keep pace with the changing market.
1. INTRODUCTION
1.1 Asia-Pacific Simulation Market Overview
2. EXECUTIVE SUMMARY
3. MARKET ANALYSIS
3.1 Comparative Analysis
3.2 Product bench marking
3.3 Patent bench marking
4. MARKET SEGMENTATION
4.1 Market Segmentation, By Products
4.1.1 Software
4.1.1.1 - Behavior analysis software
4.1.1.2 - Management software
4.1.2 Human Patient Simulators
4.1.2.1 Human
4.1.2.2 Pediatric
4.1.2.3 Surgical
4.1.2.4 Obstetrics
4.1.3 Interventional simulation
4.1.3.1 - Endovascular simulators
4.1.3.2 - Surgical simulators
4.1.3.4 - Cardiovascular simulators
4.1.3.5 - Ultrasound simulators
4.1.3.6 - IV simulators
4.1.3.7 - Others
4.1.4 Task traines/ Low fidelity
4.1.4.1 Mid-Fidelity Full Body Manikins
4.1.4.2 - Low-Fidelity Limbs
4.1.5 Anciliary products
4.1.5.1 Patient monitors
4.1.5.2 - Ventilators
4.1.5.3 - Thermometers
4.1.5.4 - Masks
4.1.5.5 - Others
4.1.6 Imaging simulation
4.1.6.1 - Magnetic Resonance Imaging (MRI)
4.1.6.2 - Ultrasound Imaging
4.1.6.3 - Positron Emission Tomography
4.1.6.4 - Computed Tomography (CT)
4.1.7 Simulation education
4.1.7.1 Custom Consulting
4.1.7.2 - Vendor Based Training
4.1.7.3 - Laerdal Sun
4.1.7.4 - CAE Healthcare HPSN
4.1.7.5 - Educational Societies
4.1.7.6 - Others
4.1.8 Simulated Clinical Enviornments
4.1.8.1 Live environments
4.1.8.2 Virtual environments
4.1.8.3 - Second life
4.1.8.4 - Serious games
4.2 Market segmentation, By Application
4.2.1 Academics
4.2.2 Hospitals
4.2.3 Military
4.2.4 Others
4.3 Market Segmentation, By geography
4.3.1 Asia-Pacific
4.3.1.1 India
4.3.1.2 China
4.3.1.3 Japan
5. COMPETITIVE LANDSCAPE
5.1 Introduction
5.2 New product launches
5.3 Market strategies
5.4 Agreements, Partnerships & expansion
5.5 Mergers and Acquisitions
5.6 Market Share Analysis
6.COMPANY PROFILES
6.1 B Scientific Gmbh
6.1.1 Company overview
6.1.2 Financial overview
6.1.3 Product portfolio
6.1.4 Business strategies
6.1.5 Recent developments
6.2 Anesoft Corporation
6.2.1 Company overview
6.2.2 Financial overview
6.2.3 Product portfolio
6.2.4 Business strategies
6.2.5 Recent developments
6.3 Anomalous Medical
6.3.1 Company overview
6.3.2 Financial overview
6.3.3 Product portfolio
6.3.4 Business strategies
6.3.5 Recent developments
6.4 Biodigital Systems, Llc
6.4.1 Company overview
6.4.2 Financial overview
6.4.3 Product portfolio
6.4.4 Business strategies
6.4.5 Recent developments
6.5 B-Line Medical, Llc (Subsidiary Ofatellis, Inc. )
6.5.1 Company overview
6.5.2 Financial overview
6.5.3 Product portfolio
6.5.4 Business strategies
6.5.5 Recent developments
6.6 CAE, Ltd.
6.6.1 Company overview
6.6.2 Financial overview
6.6.3 Product portfolio
6.6.4 Business strategies
6.6.5 Recent developments
6.7 Education Management Solutions, Inc. (EMS)
6.7.1 Company overview
6.7.2 Financial overview
6.7.3 Product portfolio
6.7.4 Business strategies
6.7.5 Recent developments
6.8 Gaumard Scientific Company
6.8.1 Company overview
6.8.2 Financial overview
6.8.3 Product portfolio
6.8.4 Business strategies
6.8.5 Recent developments
6.9 Immersion Corporation
6.9.1 Company overview
6.9.2 Financial overview
6.9.3 Product portfolio
6.9.4 Business strategies
6.9.5 Recent developments
6.10 Ingmar Medical, Ltd.
6.10.1 Company overview
6.10.2 Financial overview
6.10.3 Product portfolio
6.10.4 Business strategies
6.10.5 Recent developments
6.11 Ingmar Medical, Ltd.
6.11.1 Company overview
6.11.2 Financial overview
6.11.3 Product portfolio
6.11.4 Business strategies
6.11.5 Recent developments
6.12 Kyoto Kagaku Co., Ltd.
6.12.1 Company overview
6.12.2 Financial overview
6.12.3 Product portfolio
6.12.4 Business strategies
6.12.5 Recent developments
7. Appendix
7.1 . Abbreviations
7.2. Sources
7.3. Bibliography
7.4. Disclaimer
